- Following ASH 2020, Amgen (NASDAQ:AMGN) will host a webcast for investors on Tuesday, December 8, at 4:00 pm ET on its oncology and hematology programs with a particular focus on its BiTE platform, including late-stage pediatric data on Blincyto (blinatumomab) and the first clinical results on AMG 701.
- https://seekingalpha.com/news/3641518-amgen-to-host-investor-event-on-bite-platform-december-8
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.